The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 09, 2024
Filed:
Apr. 20, 2021
Applicant:
Camurus Ab, Lund, SE;
Inventors:
Assignee:
CAMURUS AB, Lund, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/485 (2006.01); A61K 47/12 (2006.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01); A61K 47/44 (2017.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 9/0024 (2013.01); A61K 31/485 (2013.01); A61K 47/12 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A61K 47/44 (2013.01);
Abstract
The present invention provides an injectable liquid formulation comprising: a) a lipid controlled-release matrix comprising at least 50% triacyl lipids; b) at least one oxygen containing organic solvent; c) at least 16% by weight of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base. The invention also provides a method for the treatment of pain, for opioid maintenance therapy or for the treatment of opioid dependence by detoxification and/or maintenance or for the treatment or prophylaxis of the symptoms of opioid withdrawal and/or cocaine withdrawal by injecting such a liquid composition.